Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategies
David M. Brett‐Major(Apple (Israel)), Paul T. Scott(Walter Reed Army Institute of Research), Laura A. Pacha(Naval Medical Research Command), Adam W. Armstrong(Uniformed Services University of the Health Sciences), Jennifer Malia(Walter Reed Army Institute of Research), Shilpa Hakre(Walter Reed Army Institute of Research), Sheila A. Peel(Henry M. Jackson Foundation), Linda L. Jagodinski(Walter Reed Army Institute of Research), Kevin D. Frick(National Heart Lung and Blood Institute), Nelson L. Michael(Walter Reed Army Institute of Research), Francisco J. Rentas, Michael A. Forgione, Hala H. Maktabi(Naval Medical Research Command), P. L. Gould(United States Air Force), Aatif M. Hayat(Naval Medical Research Command), Charmagne Beckett(United States Department of the Army), Steven B. Cersovsky(United States Army Medical Command), Jason F. Okulicz(Gilead Sciences (United States)), Stephen A. Harrison(Pinnacle Clinical Research), Angelia A Eick-Cost(Henry M. Jackson Foundation), Peter Dawson(Emmes (United States)), Clinton K. Murray(Joint Commission)
Cited by 10
Related Papers
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
|New England Journal of Medicine|2009|3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k